[HTML][HTML] A contemporary review on pathogenesis and immunity of COVID-19 infection

R Mirzaei, S Karampoor, M Sholeh, P Moradi… - Molecular biology …, 2020 - Springer
Emerging of the COVID-19 pandemic has raised interests in the field of biology and
pathogenesis of coronaviruses; including interactions between host immune reactions …

[HTML][HTML] Molecular pathogenesis, immunopathogenesis and novel therapeutic strategy against COVID-19

SK Chatterjee, S Saha, MNM Munoz - Frontiers in molecular …, 2020 - frontiersin.org
The coronavirus disease 2019 (COVID-19), is a highly contagious transmittable disease
caused by a recently discovered coronavirus, pathogenic SARS-CoV-2. Followed by the …

[HTML][HTML] COVID-19: systemic pathology and its implications for therapy

Q Shen, J Li, Z Zhang, S Guo, Q Wang… - … Journal of Biological …, 2022 - ncbi.nlm.nih.gov
Responding to the coronavirus disease 2019 (COVID-19) pandemic has been an
unexpected and unprecedented global challenge for humanity in this century. During this …

[HTML][HTML] Targeting macrophages as a therapeutic option in coronavirus disease 2019

M Gracia-Hernandez, EM Sotomayor… - Frontiers in …, 2020 - frontiersin.org
Immune cells of the monocyte/macrophage lineage are characterized by their diversity,
plasticity, and variety of functions. Among them, macrophages play a central role in antiviral …

Tackling the cytokine storm in COVID-19, challenges and hopes

SM Abdin, SM Elgendy, SK Alyammahi, DW Alhamad… - Life Sciences, 2020 - Elsevier
The outbreak of Coronavirus disease 2019 (COVID-19) is the current world health concern,
presenting a public health dilemma with ascending morbidity and mortality rates exceeding …

[HTML][HTML] Novel therapeutic approaches for treatment of COVID-19

N Hossein-Khannazer, B Shokoohian… - Journal of Molecular …, 2020 - Springer
To date, there is no licensed treatment or approved vaccine to combat the coronavirus
disease of 2019 (COVID-19), and the number of new cases and mortality multiplies every …

[HTML][HTML] The COVID-19 cytokine storm; what we know so far

D Ragab, H Salah Eldin, M Taeimah… - Frontiers in …, 2020 - frontiersin.org
COVID-19 is a rapidly spreading global threat that has been declared as a pandemic by the
WHO. COVID-19 is transmitted via droplets or direct contact and infects the respiratory tract …

Identifying the natural polyphenol catechin as a multi-targeted agent against SARS-CoV-2 for the plausible therapy of COVID-19: an integrated computational …

CB Mishra, P Pandey, RD Sharma… - Briefings in …, 2021 - academic.oup.com
The global pandemic crisis, coronavirus disease 2019 (COVID-19), caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has claimed the lives of millions of …

[HTML][HTML] SARS-CoV-2: structure, biology, and structure-based therapeutics development

MY Wang, R Zhao, LJ Gao, XF Gao… - Frontiers in cellular …, 2020 - frontiersin.org
The pandemic of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has been posing great threats to the world in many aspects. Effective therapeutic and …

[HTML][HTML] What is currently known about the role of CXCL10 in SARS-CoV-2 infection?

M Gudowska-Sawczuk, B Mroczko - International Journal of Molecular …, 2022 - mdpi.com
Dysregulation of the immune response plays an important role in the progression of SARS-
CoV-2 infection. A “cytokine storm”, which is a phenomenon associated with uncontrolled …